Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
375
Total Claims
$2.3M
Drug Cost
85
Beneficiaries
$27K
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,372 Medical Oncology providers
+37%
Opioid rate vs peers
8.0% vs 5.9% avg
+123%
Cost per patient vs peers
$27K vs $12K avg
+136%
Brand preference vs peers
31.7% vs 13.4% avg
Opioid Prescribing
8.0%
Opioid Rate
30
Opioid Claims
$725
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 119 claims · $2.3M
Generic: 256 claims · $9,163
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lenvatinib Mesylate | 66 | $1.6M |
| Pemigatinib | 29 | $544K |
| Mirtazapine | 12 | $746 |
| Prochlorperazine Maleate | 20 | $478 |
| Ondansetron Hcl | 24 | $262 |
| Spironolactone | 16 | $192 |
| Furosemide | 25 | $92 |
Prescribing Profile
7
Unique Drugs
3.0
Anomaly Score
Patient Profile
73
Avg Age
40%
Female
2.93
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About